COSTA, Francesco
 Distribuzione geografica
Continente #
EU - Europa 2.404
NA - Nord America 1.933
AS - Asia 1.521
SA - Sud America 560
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 6.486
Nazione #
US - Stati Uniti d'America 1.878
RU - Federazione Russa 1.001
SG - Singapore 744
BR - Brasile 494
IE - Irlanda 409
IT - Italia 292
HK - Hong Kong 252
CN - Cina 249
SE - Svezia 228
DE - Germania 119
VN - Vietnam 119
FI - Finlandia 70
PL - Polonia 58
GB - Regno Unito 53
AT - Austria 48
IN - India 38
FR - Francia 34
AR - Argentina 28
MX - Messico 26
CA - Canada 23
ES - Italia 19
TR - Turchia 19
MA - Marocco 17
ZA - Sudafrica 16
BD - Bangladesh 15
BE - Belgio 14
NL - Olanda 14
UA - Ucraina 14
UZ - Uzbekistan 14
ID - Indonesia 12
IQ - Iraq 12
EC - Ecuador 11
LT - Lituania 9
PY - Paraguay 8
TN - Tunisia 8
CO - Colombia 7
EG - Egitto 7
KE - Kenya 7
PK - Pakistan 6
AZ - Azerbaigian 5
IL - Israele 5
JP - Giappone 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
MY - Malesia 4
PT - Portogallo 4
BO - Bolivia 3
CH - Svizzera 3
DK - Danimarca 3
JM - Giamaica 3
KZ - Kazakistan 3
OM - Oman 3
PE - Perù 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
CL - Cile 2
DZ - Algeria 2
GY - Guiana 2
LB - Libano 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
LU - Lussemburgo 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 6.486
Città #
Moscow 547
Dublin 409
Ashburn 393
Singapore 343
Dallas 274
Hong Kong 248
Chandler 186
Nyköping 165
Messina 112
Beijing 100
Los Angeles 69
Munich 57
Warsaw 55
Ho Chi Minh City 53
New York 47
The Dalles 47
São Paulo 44
Dearborn 31
Vienna 31
Bremen 26
Jacksonville 26
Princeton 26
Redondo Beach 26
Ann Arbor 25
Buffalo 24
Rome 24
Medford 23
Phoenix 23
Des Moines 22
London 19
Helsinki 18
Turku 18
Denver 16
Hanoi 16
Belo Horizonte 15
Brasília 15
Rio de Janeiro 15
Tianjin 15
Boardman 14
Brussels 14
Lappeenranta 14
Milan 14
Nuremberg 14
Tashkent 14
Houston 13
Brooklyn 12
Chicago 12
Chennai 11
Montreal 11
Cambridge 10
Campinas 10
Porto Alegre 10
Springfield 10
Amsterdam 9
Boston 9
Catania 9
Düsseldorf 9
Mexico City 9
Pune 9
Nanjing 8
San Marcellino 8
Santa Clara 8
Stockholm 8
Ankara 7
Atlanta 7
Goiânia 7
Guangzhou 7
Jakarta 7
Manchester 7
Nairobi 7
Newark 7
Salvador 7
San Francisco 7
Curitiba 6
Fort Worth 6
Hyderabad 6
Johannesburg 6
Los Lunas 6
Poplar 6
San Mateo 6
Seattle 6
Washington 6
Altoona 5
Da Nang 5
Frankfurt am Main 5
Haikou 5
Istanbul 5
Jinan 5
Orem 5
Prineville 5
Quito 5
Tel Aviv 5
Tokyo 5
Tunis 5
Baghdad 4
Baku 4
Cagliari 4
Carrara 4
Créteil 4
Dong Ket 4
Totale 4.080
Nome #
Correlations between genetic mutations, biomolecular patterns and elastic properties of the aorta in patients with bicuspid aortic valve. 204
686 Coronary lesion distribution in young patient presenting with acute coronary syndrome 152
752 Acute coronary syndrome in young patients: long-term follow-up and quality of life assessment 146
Impellent impeller-Switching intra-aortic balloon pump to IMPELLA-CP after ST-segment elevation myocardial infarction and refractory cardiogenic shock 144
Elastin and aortopathy in bicuspid aortic valve: correlations between genetic and biomolecular patterns and mechanical properties of the aorta 141
A Very Late Atrial Septal Erosion After an Ostium Secundum Percutaneous Closure 138
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial 136
Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value 135
A meta-analysis of 22108 patients undergoing PCI: can radial approach reduce the incidence of acute kidney injury? 133
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies-meta-analysis of prospective studies 127
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 125
P1468Non-invasive myocardial work indices in ischemic heart disease 119
Radial Artery Access for Percutaneous Cardiovascular Interventions: Contemporary Insights and Novel Approaches 118
Appraising the counter-balancing ischemia and bleeding risks for dual antiplatelet therapy duration after coronary stenting 115
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 114
57 ISCHEMIC HEART SCOMBROID SYNDROME: FURTHER EVIDENCE FROM ALL OVER THE WORLD 112
Benefit of radial approach in reducing the incidence of acute kidney injury after percutaneous coronary intervention: A meta-analysis of 22,108 patients 112
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: Results of an EAPCI survey 111
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways 111
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 101
Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials 91
Antithrombotic therapy for percutaneous cardiovascular interventions: From coronary artery disease to structural heart interventions 89
Left Main Coronary Artery 88
Analysis of changes in "mitral valve reserve" after coronary artery bypass grafts in patients with functional mitral regurgitation 87
Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management—A Narrative Review 87
A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making 86
Impact of vascular access on acute kidney injury after percutaneous coronary intervention 85
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis 84
Percutaneous Coronary Intervention before or after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Involving 1531 Patients 83
Chest Pain and the Dynamic Evolution of Spontaneous Coronary Artery Hematoma 82
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI 82
Alcohol septal ablation: An option on the rise in hypertrophic obstructive cardiomyopathy 80
Echocardiographic Evolution of PosteroLateral Left Ventricular Aneurysm with Normal Coronary Arteries in Patient Recently COVID-19 Vaccinated: A Complicated Atypical Case of Takotsubo Syndrome Vaccine-related? 80
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 80
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 79
Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy 78
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation 78
Mental health status and sexual habits in young patient after acute coronary syndrome 77
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 76
Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study 75
The High Bleeding Risk Patient with Coronary Artery Disease 75
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 73
Impact of a 24- rather than 6-month dual antiplatelet therapy with clopidogrel in patients with left main or proximal left anterior descending coronary artery disease. A post hoc analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent ­Induced Intimal Hyperplasia) PRODIGY trial 73
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management 71
Distribution of wall motion abnormalities in young patients presenting with acute coronary syndrome 71
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 69
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 67
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 67
Exploring the Incremental Value of CRUSADE Score as Clinical Guidance for the Decision-Making of Dual Antiplatelet Therapy Duration: A Retrospective Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial Pathway 67
Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach? 67
Bleeding risk in patients undergoing percutaneous coronary intervention: how to define, identify and treat high-risk patients 67
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 66
ELECTRICAL STORM IN ISCHAEMIC HEART DISEASE: A CASE OF LEFT STELLATE GANGLION BLOCK AS BRIDGE TO URGENT PCI RESCUE 63
Anatomic Characteristics and Clinical Implications of Angiographic Coronary Thrombus 59
A Look Beyond Statins and Ezetimibe: a Review of Other Lipid-Lowering Treatments for Cardiovascular Disease Prevention in High-Risk Patients 58
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 58
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 55
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 55
MVP ECG risk score predicts early occurrence of atrial fibrillation after patent foramen ovale percutaneous closure 54
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 54
Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials 54
Advances in Acute Coronary Syndromes: Bridging Gaps in Diagnosis and Treatment 54
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease 51
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 44
Impact of Clinical Presentation on Ischemic and Bleeding Outcomes in Patients Receiving 6 or 24 Month Duration of Dual Antiplatelet Therapy After Stent Implantation: A Pre-Specified Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial 44
Moderate conscious sedation for transesophageal echocardiography guidance of percutaneous left atrial appendage closure: The MID-DEX protocol 43
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease 42
In-stent restenosis of superficial femoral artery: use all arrows in the quiver 38
Aspirin-Free Strategy After ACS Implementing Colchicine: Looking for a Substitution? 36
Catheter-based techniques for pulmonary embolism treatment 36
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial 35
Chronic Thrombocytopenia and Percutaneous Coronary Intervention: The Virtue of Prudence ∗ 35
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization 34
Characterization of the Individual Patient Risk After Percutaneous Coronary Intervention: At the Crossroads of Bleeding and Thrombosis 32
Spectral CT Imaging of Prosthetic Valve Embolization after Transcatheter Aortic Valve Implantation 31
null 28
Myocardial ischemia due to a recanalized chronic coronary thrombus: Angiographic and optical coherence tomography imaging insights 28
Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis 26
Vacuum-assisted thrombectomy of massive inferior vena cava thrombosis 25
“Ticagrelor or Prasugrel, Doctor?” The Basis for Decision in Clinical Practice 25
How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators 24
Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients 23
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke 21
Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium 21
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI 21
Distal radial artery access for percutaneous coronary intervention: Convincing the sceptical cardiologist 21
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 21
Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease 20
New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine 19
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome 19
Transfusion and Mortality After Transcatheter Aortic Valve Replacement 19
Inhibidores selectivos de la recaptacion de serotonina y riesgo hemorragico tras ICP. Un estudio con puntuacion de propension 19
Impact of greater than 12-month dual antiplatelet therapy duration on mortality: Drug-specific or a class-effect? A meta-analysis 18
The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19 17
The optimal duration of dual antiplatelet therapy after coronary stent implantation: To go too far is as bad as to fall short 17
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial 17
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies 17
Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score 16
Advanced Management of Patients Undergoing Transcatheter Treatment for Pulmonary Embolism: Evidence-Based Strategies for Optimized Patient Care 15
DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients 15
Totale 6.651
Categoria #
all - tutte 25.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021110 0 0 0 0 0 16 13 25 8 38 4 6
2021/2022207 2 15 15 6 4 8 19 3 5 39 23 68
2022/2023998 31 86 40 29 70 124 18 75 488 9 22 6
2023/2024341 21 27 17 39 24 73 70 16 8 21 1 24
2024/20251.701 20 14 16 150 111 135 74 220 369 126 156 310
2025/20263.088 347 316 408 423 463 1.131 0 0 0 0 0 0
Totale 6.767